Sivik Global Healthcare LLC Eli Lilly & CO Transaction History

Sivik Global Healthcare LLC

$236 Million
Q3 2024

A detailed history of Sivik Global Healthcare LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sivik Global Healthcare LLC holds 14,500 shares of LLY stock, worth $10.8 Million. This represents 5.44% of its overall portfolio holdings.

Number of Shares

14,500

Previous 15,000 3.33%

Holding current value

$10.8 Million

Previous $13.6 Million 5.41%

% of portfolio

5.44%

Previous 4.88%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $386,070 - $480,010	-500 Reduced 3.33%	14,500 $12.8 Million
Q2 2024 Jul 29, 2024	SELL	$724.87 - $909.04 $724,870 - $909,040	-1,000 Reduced 6.25%	15,000 $13.6 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $592,200 - $792,280	1,000 Added 6.67%	16,000 $12.4 Million
Q3 2023 Nov 06, 2023	SELL	$434.7 - $599.3 $1.09 Million - $1.5 Million	-2,500 Reduced 14.29%	15,000 $8.06 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $876,850 - $1.17 Million	-2,500 Reduced 12.5%	17,500 $8.21 Million
Q1 2023 May 05, 2023	BUY	$310.63 - $364.82 $776,575 - $912,050	2,500 Added 14.29%	20,000 $6.87 Million
Q3 2022 Nov 04, 2022	SELL	$296.48 - $337.87 $1.19 Million - $1.35 Million	-4,002 Reduced 18.61%	17,500 $5.66 Million
Q2 2022 Aug 10, 2022	BUY	$278.73 - $327.27 $3.21 Million - $3.76 Million	11,502 Added 115.02%	21,502 $6.97 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $4.11 Million - $5.1 Million	-17,500 Reduced 63.64%	10,000 $2.86 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $1.69 Million - $2.09 Million	-7,500 Reduced 21.43%	27,500 $7.6 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $1.11 Million - $1.36 Million	-5,000 Reduced 12.5%	35,000 $8.09 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $7.22 Million - $9.34 Million	40,000 New	40,000 $9.18 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $5.75 Million - $7.45 Million	-35,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $2.61 Million - $3.45 Million	-20,000 Reduced 36.36%	35,000 $5.91 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $8.04 Million - $9.3 Million	55,000 New	55,000 $8.14 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $8.19 Million - $9.85 Million	-60,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $1.19 Million - $1.47 Million	10,000 Added 20.0%	60,000 $4.39 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $534,600 - $662,150	-5,000 Reduced 9.09%	50,000 $6.57 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $1.66 Million - $1.94 Million	-15,000 Reduced 21.43%	55,000 $6.09 Million
Q1 2019 May 08, 2019	BUY	$111.31 - $131.02 $1.67 Million - $1.97 Million	15,000 Added 27.27%	70,000 $9.08 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $1.59 Million - $1.78 Million	-15,000 Reduced 21.43%	55,000 $6.37 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $858,600 - $1.07 Million	-10,000 Reduced 12.5%	70,000 $7.51 Million
Q2 2018 Aug 06, 2018	BUY	$75.7 - $86.88 $6.06 Million - $6.95 Million	80,000 New	80,000 $6.83 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.

Account

Sivik Global Healthcare LLC Eli Lilly & CO Transaction History